As of 2025-06-27, the Relative Valuation of Altimmune Inc (ALT) is (6.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.61 USD, the upside of Altimmune Inc based on Relative Valuation is -284.0%.
The range of the Relative Valuation is (4.81) - (9.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 17.6x | 12.5x |
| Forward P/E multiples | 9.2x - 20.0x | 13.0x |
| Fair Price | (4.81) - (9.18) | (6.64) |
| Upside | -233.3% - -354.3% | -284.0% |
| Date | P/E |
| 2025-06-26 | -6.93 |
| 2025-06-25 | -14.80 |
| 2025-06-24 | -13.80 |
| 2025-06-23 | -13.42 |
| 2025-06-20 | -13.50 |
| 2025-06-18 | -13.02 |
| 2025-06-17 | -13.23 |
| 2025-06-16 | -13.19 |
| 2025-06-13 | -13.28 |
| 2025-06-12 | -13.73 |
| 2025-06-11 | -12.55 |
| 2025-06-10 | -12.94 |
| 2025-06-09 | -11.42 |
| 2025-06-06 | -10.79 |
| 2025-06-05 | -10.48 |
| 2025-06-04 | -10.54 |
| 2025-06-03 | -10.40 |
| 2025-06-02 | -10.17 |
| 2025-05-30 | -10.42 |
| 2025-05-29 | -10.77 |
| 2025-05-28 | -10.54 |
| 2025-05-27 | -10.58 |
| 2025-05-23 | -10.96 |
| 2025-05-22 | -11.08 |
| 2025-05-21 | -10.73 |
| 2025-05-20 | -11.23 |
| 2025-05-19 | -10.56 |
| 2025-05-16 | -10.71 |
| 2025-05-15 | -11.10 |
| 2025-05-14 | -10.94 |
| 2025-05-13 | -11.06 |
| 2025-05-12 | -11.54 |
| 2025-05-09 | -10.73 |
| 2025-05-08 | -11.13 |
| 2025-05-07 | -10.29 |
| 2025-05-06 | -9.66 |
| 2025-05-05 | -10.42 |
| 2025-05-02 | -11.08 |
| 2025-05-01 | -9.92 |
| 2025-04-30 | -10.08 |
| 2025-04-29 | -9.79 |
| 2025-04-28 | -9.71 |
| 2025-04-25 | -9.73 |
| 2025-04-24 | -9.92 |
| 2025-04-23 | -9.54 |
| 2025-04-22 | -9.31 |
| 2025-04-21 | -9.20 |
| 2025-04-17 | -8.73 |
| 2025-04-16 | -8.45 |
| 2025-04-15 | -8.70 |